PMID: 298 LiuZWangMLeiYXuKFanL
Additionally, BPC-157 interacts with the dopaminergic and serotonergic systems, which may explain its observed neuroprotective properties in preclinical models of traumatic brain injury and nerve damage
It is central to the redox reactions that power cellular energy metabolism
Peptides depend on a sufficient amino acid pool, and most adults, especially those over 40, do not eat enough

Injection Debate Community discussion reveals ongoing debate about administration routes: Oral/Sublingual Advocates Argue: BPC-157 originates from gastric proteins and works locally in the gut Oral administration is simpler and less intimidating Some users report excellent gut-related results with oral administration The peptide's acid stability supports oral viability Injection Advocates Argue: More consistent systemic absorption Can target injection site near injury location Most research has used injection methods Concerns about degradation even with acid-stable peptides Community Consensus: A general consensus has emerged that: Oral/sublingual may be preferable for gut-related applications Injection may be preferable for localized injuries (tendons, muscles) Some users employ both routes simultaneously Side Effects and Safety Profile Animal Study Safety Data The extensive animal research on BPC-157 has shown a remarkably favorable safety profile [22]: No observed LD50 (lethal dose) has been established, as studies have not found doses causing toxicity No organ toxicity observed at doses far exceeding therapeutic ranges No carcinogenic effects demonstrated No mutagenic effects in testing No reproductive toxicity observed This exceptional safety profile in animal studies is frequently cited, though translation to humans cannot be assumed

Personal experiences with growth hormone secretagogues, such as smearin, have shown significant effects on sleep patterns, with increased deep sleep and decreased REM sleep, highlighting the need for further research into the effects of these substances 15m10s